Family Pact FP Coverage Guide

Similar documents
Medicaid Family Planning Waiver Services CPT Codes and ICD-10 Diagnosis Codes

Chapter 11. Sexually Transmitted Diseases

LOUISIANA MEDICAID PROGRAM ISSUED: 11/25/14 REPLACED: 10/16/14 CHAPTER 48: FAMILY PLANNING TAKE CHARGE PLUS APPENDIX A: DIAGNOSIS CODES PAGE(S) 9

Sexually transmitted infections (in women)

Sexually Transmitted Disease Treatment Tables

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Sexually transmitted infections (in women)

Answers to those burning questions -

SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5)

Drugs for UTIs and STDs. Dr.Vishaal Bhat Associate Professor MMMC Manipal

CODING GUIDELINES FOR CONTRACEPTIVES. Effective June 1, 2017 Version 1.40

Family Planning Eligibility Program

Nothing to disclose.

Sexually Transmitted Infections: New Tests, New Guidelines

5/1/2017. Sexually Transmitted Diseases Burning Questions

Categories of STI Screening and Testing Routine screening Population based risk factors Targeted screening Personal behavioral risk factors Contact te

1.Abstinence no sex (Abstinence only education has been proven ineffective in preventing unwanted pregnancies)

FOR CALENDAR YEAR 2014 DATA

Dermatologist Venereologist MD, PhD

Management that provides continuity of care for women

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014

CLINICAL MANAGEMENT OF STDS

Gynaecology. Pelvic inflammatory disesase

SEXUALLY TRANSMITTED INFECTIONS IN ST LOUIS

Bradford Contraception and Sexual Health Services FORMULARY

The (likely) New 2010 CDC STD Treatment Guidelines Guideline Development Process. Overview

20. VAGINITIS AND SEXUALLY TRANSMITTED DISEASES 5. Allison L. Diamant, MD, MSPH, and Eve Kerr, MD, MPH

Syphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference

INTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management

STDs and Hepatitis C

PROPOSED REGULATION OF THE STATE BOARD OF HEALTH. LCB File No. R July 30, 1997

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

What Bugs You? A Sexually Transmitted Infection Review

Sexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System

Sexually Transmitted Diseases

Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

OBSOLETE. NOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied.

What's the problem? - click where appropriate.

Alberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2008

Update on Sexually Transmitted Infections among Persons Living with HIV

Edward W. Hook, III, M.D.

Timby/Smith: Introductory Medical-Surgical Nursing, 9/e

2/17/2017. Sexually Transmitted Diseases in Children: Is it Abuse? General Considerations. Judy Guinn, MD WI CAN Educational Series February 17, 2017

Sexually Transmi/ed Diseases

S403- Update on STIs for the Generalists

5/12/11. STI s in Adolescents: Exposing the Hidden Epidemic. Why the hidden epidemic?

Genital Tract Infections in Women. Michael S. Policar, MD, MPH UCSF School of Medicine

ADOPTED REGULATION OF THE STATE BOARD OF HEALTH. LCB File No. R Effective December 3, 2003

Challenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A

STIs in Primary Care. Dr Eleanor Draeger 19 th January 2016

REPRODUCTIVE TRACT INFECTIONS

Investigation and Management of Vaginal Discharge in Adult Women

WHAT DO U KNOW ABOUT STIS?

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017

Stephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os

Complex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes ReachMD Page 1 of 5

SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization

Vaginitis. Antibiotics Changes in hormone levels due to pregnancy, breastfeeding, or menopause Douching Spermicides Sexual intercourse Infection

Sexually Transmitted Infection surveillance in Northern Ireland An analysis of data for the calendar year 2011

Sexually Transmitted Diseases. David T. Bearden, Pharm.D. Clinical Associate Professor

STI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research

Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

PROCEDURE/DIAGNOSIS/REVENUE CODES

NOTE: Please append modifier 33 when indicated. If modifier 33 is not appended, regular plan benefits will be applied.

Contraception update. Gina M. Brown, M.D.

Contraception update. Gina M. Brown, M.D.

Be Healthy. Be Healthy. Using Your Wellness Benefits. Helping You Stay Healthy. Wellness Benefits

CHAPTER 26 - Microbial Diseases of the Urinary and Reproductive System

Unit 9 CONTRACEPTION LEARNING OBJECTIVES

GUIDELINES FOR THE MANAGEMENT OF SEXUALLY TRANSMITTED INFECTIONS

4/6/17 UNPRECEDENTED HIGH. Shelagh Larson, RNC, WHNP, NCMP

Welcome to: Coding Scenarios for STD Clinic Visits. We will begin in a few minutes. There will be no sound until the webinar starts.

STIs: Practical Aspects of Management

Advances in STI diagnostics. Dr Paddy Horner Consultant Senior Lecturer University of Bristol

Emerging Issues in STDs and Resistance

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]

Chapter 101 Department of Health and Human Services MAINECARE BENEFITS MANUAL Chapter X. Section 4 LIMITED FAMILY PLANNING BENEFIT 10/01/16

LABORATORY DIAGNOSIS SEXUALLY TRANSMITTED DISEASES

Birth Control Options Chart

Integrating HIV Screening Into

POLICY RESEARCH BRIEF MARCH 2009

Contraceptives. Kim Dawson October 2010

Clinical Cases from the STD Clinical Consultation Network

STI Indicators by STI

Gonococcal Infection- Treatment Consideration

Be Healthy. Be Healthy. Using Your Wellness Benefits. Helping You Stay Healthy. Wellness Benefits

Further Reading. Bunker C. Male Genital Skin Disease. Elsevier Saunders, London 2004.

2

2017 NBCCEDP Allowable Procedures and Relevant CPT Codes

Case Study 1. Cervical Cancer Screening and Sexually Transmitted Infections Case Studies

CASE-BASED SMALL GROUP DISCUSSION MHD II SESSION 6. Friday, MARCH 18, 2016 STUDENT COPY

STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention

Percentage of family planning clinics, according to clinic characteristics, by service focus, Title X funding status and clinic type, 2010 and 2015

Microbial Diseases of the Urinary and Reproductive Systems

Learning Objectives. STI Update. Case 1 6/1/2016

If you are sexually active, desire birth control or have other concerns, you should schedule a women s health h visit.

WHAT ARE CONTRACEPTIVES?

Clinical Prevention Behavioral Prevention Counseling

Transcription:

Family Pact FP Coverage Guide Overview Guide ONLY. Consult billing for up-to-date information. Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z30.012 Encounter for prescription of emergency contraception Z30.09 Encounter for general counseling and advice on contraception (33) 81025: Urine pregnancy test 81025: Urine pregnancy test (32) J3490U5: Ulipristal acetate (ECP) J3490U6: Levonorgestrel (ECP) Z30.011 Z30.41 Initial prescription, contraceptive pills Surveillance, contraceptive pills 99000: Handling and/or conveyance of blood specimen to unaffiliated lab 81025: Urine pregnancy test A4267: Male A4268: Female Spermicides: A4269U1: Gel, jelly, cream, or foam S4993: Oral Contraceptives : Estradiol (requires additional code N92.1) J3490U5: Ulipristal acetate (ECP) J3490U6: Levonorgestrel (ECP) A4269U2: Suppository Z30.015 Initial prescription, vaginal ring A4269U3: Vaginal film J7304: Contraceptive transdermal patch Z30.44 Z30.016 Surveillance, vaginal ring Initial prescription, transdermal patch A4269U4: Sponge S5199: Lubricant J7303: Contraceptive vaginal ring : Estradiol (requires additional code N92.1) Z30.45 Surveillance, transdermal patch J3490U5: Ulipristal acetate (ECP) J3490U6: Levonorgestrel (ECP)

2 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z30.013 Z30.42 Initial prescription, injectable contraceptive Surveillance, injectable contraceptive 99000: Handling and/or conveyance of blood specimen to unaffiliated lab 81025: Urine pregnancy test A4267: Male A4268: Female Spermicides: J3490U8: Medroxy-progesterone acetate for contraception : Estradiol (requires additional code N92.1) J3490U5: Ulipristal acetate (ECP) A4269U1: Gel, jelly, cream, or foam A4269U2: Suppository A4269U3: Vaginal film A4269U4: Sponge S5199: Lubricant J3490U6: Levonorgestrel (ECP)

3 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z30.017 Z30.46 Initial prescription, subdermal implant Surveillance, subdermal implant 11976: Removal 11981: Insertion 99000: Handling and/or conveyance of blood specimen to unaffiliated lab 73060: X-ray humerus (34) 76882: Ultrasound extremity nonvascular (34) 81025: Urine pregnancy test 11976UA: Removal A4267: Male A4268: Female Spermicides: A4269U1: Gel, cream, jelly, or foam A4269U2: Suppository A4269U3: Vaginal film A4269U4: Sponge S5199: Lubricant J7307: Etonogestrel implant : Estradiol (requires code N92.1) J3490U5: Ulipristal acetate (ECP) J3490U6: Levonorgestrel (ECP)

4 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z30.430 Z30.431 Z30.432 Z30.433 Insertion, intrauterine contraceptive device Routine checking, intrauterine contraceptive device Removal of intrauterine contraceptive device Removal and reinsertion of intrauterine contraceptive device 58300: Insertion 58301: Removal 74000: KUB (6) 76830: Transvag US (6) 76857: US pelvic limited or F/U (6) 99000: Handling and/or conveyance of blood specimen to unaffiliated lab 81025: Urine pregnancy test 85013, 85014: Hematocrit 85018: Hemoglobin 58300UA: Insertion 58301UA: Removal A4267: Male A4268: Female Spermicides: A4269U1: gel, jelly, cream or foam A4269U2: Suppository A4269U3: Vaginal film A4269U4: Sponge S5199: Lubricant J7297: Levonorgestrel IU 52 mg 3 yr J7298: Levonorgestrel IU 52 mg 5 yr J7300: Intrauterine copper contraceptive J7301: Levonorgestrel IU 13.5 mg J3490U5: Ulipristal acetate (ECP) J3490U6: Levonorgestrel (ECP) : Estradiol (requires code N92.1)

5 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z30.018 Z30.49 Initial prescription of other contraceptives (male or female barrier and/or spermicide) Surveillance of other contraceptives (male or female barriers and/or spermicide) 57170: Diaphragm/ cervical cap fitting 99000: Handling and/or conveyance of blood specimen to unaffiliated lab 81025: Urine pregnancy test A4267: Male A4268: Female Spermicides: A4269U1: Gel, jelly, cream, or foam A4269U2: Suppository A4269U3: Vaginal film J3490U5: Ulipristal acetate (ECP) J3490U6: Levonorgestrel (ECP) A4269U4: Sponge Cervical cap (26) Diaphragm (26) S5199: Lubricant Z30.02 Counseling and instruction in natural family planning to avoid pregnancy 81025: Urine pregnancy test BBT (26) J3490U5: Ulipristal acetate (ECP) J3490U6: Levonorgestrel (ECP) Z31.61 Procreative counseling and advice using natural family planning (34) 81025: Urine pregnancy test BBT (26)

6 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z30.09 Z01.812 (28) Encounter general counseling and advice on contraception (sterilization) (35) Encounter for pre-procedural lab exam (female sterilization) 99000: Handling and/or conveyance of blood specimen to unaffiliated lab 81025: Urine pregnancy test Preoperative tests: 81000: UA dipstick w/microscopy 81001: UA automated w/microscopy 81002: UA dipstick w/out microscopy 81003: UA automated w/out microscopy 85013: Spun Hct 85014: Hct 85018: Hemoglobin 85025: Auto CBC w/auto diff. WBC 85027: Auto CBC w/out differential 85002: Bleeding time (27) 85610: Prothrombin time (27) 85730: thromboplastin time (27)

7 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z01.818 (28) Encounter for other pre-procedural exam (female sterilization) 71020: Chest X- ray (7) 93000: ECG (7) 93307: Echocardiography (7) (27) Z30.2 Encounter for sterilization (female) 58565: Hysteroscopic surgical placement of micro-insert(s) 58600: Mini lap TL 58615: Mini lap TL with clip 58670: Lapscope fulguration 58671: Lapscope with ring or clip 58555: Hysteroscopy, diagnostic (29) 88302: Surgical path. (two specimens) A4264 50/52: Intratubal occlusion device (micro-inserts) 58565UA/UB: Hysteroscopic surg supplies 58600UA/UB: Mini-Lap TL 58615UA/UB: Mini-Lap with clip 58670UA/UB: Lapscope fulguration 58671UA/UB: Lapscope ring or clip

8 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z98.51 Tubal ligation status A4267: Male J3490U5: Ulipristal acetate (ECP) 74740: Hysterosalpingo graphy (30) 58340: Catheterization and introduction of saline or contrast material for saline infusion sonohystero graphy [SIS] or hysterosalpingo graphy (31) A4268: Female Spermicides: A4269U1: Gel, jelly, cream or foam A4269U2: Suppository A4269U3: Vaginal film A4269U4: Sponge S5199: Lubricant J3490U6: Levonorgestrel (ECP)

9 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z01.812 (28) Encounter for pre-procedural lab exam (male sterilization) 99000: Handling and/or conveyance of blood specimen to unaffiliated lab Preoperative tests: 81000: UA dipstick w/microscopy 81001: UA automated w/microscopy 81002: UA dipstick w/out microscopy 81003: UA automated w/out microscopy 85013: Spun Hct 85014: Hct 85018: Hemoglobin 85025: Auto CBC w/auto diff. WBC 85027: Auto CBC w/out differential

10 Family Planning Services Code Description Procedures Laboratory * Supplies Medications Z30.2 Encounter for sterilization (male) 55250: Vasectomy 88302: Surgical path (two 55250UA/UB: Vasectomy specimens) Z98.52 Vasectomy status A4267: Male A4268: Female Spermicides: A4269U1: Gel, jelly, cream or foam, A4269U2: Suppository A4269U3: Vaginal film A4269U4: Sponge S5199: Lubricant

11 Reproductive Health Screening Tests Reproductive Health Screening Tests * CPT-4 Code Description 86592 VDRL, RPR 86701 HIV-1 antibody 86702 HIV-2 antibody 86703 87389 87806 HIV-1 and HIV-2 antibodies, single result HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies Reflex Testing (based on a positive screening test result) 86780 TP-confirmatory test; if positive, 86593 is required 86593 Syphilis test, non-treponemal antibody; quantitative 86689 HIV confirmatory test (e.g. Western Blot) OR 86701 and 86702 differentiation assay AND 87535 HIV - NAAT (if differentiation assay results are negative or indeterminate) Restrictions 86689 limited to HIV antibody 87491 ** 87591 ** NAAT - Chlamydia NAAT - Gonorrhea Refer to the Chlamydia Trachomatis (CT) and Neisseria gonorrhoeae (GC) screening guidelines

12 Family Planning-Related Services: Laboratory Tests CPT-4 Code Cervical Cytology Description 88142 LBC, manual screen 88143 LBC, manual screen and rescreen 88147 Smear, automated screen 88148 Smear, automated screen, manual re-screen 88164 Smear, Bethesda, manual screen 88165 88167 Smear, Bethesda, manual screen, re-screen Smear, Bethesda, manual screen, computer re-screen 88174 LBC, automated screen 88175 LBC, automated screen, manual re-screen Additional Information Refer to the Benefits: Family Planning-Related Services section in this manual for additional restrictions and claim requirements. Human Papillomavirus The following laboratory test is covered, in combination with cervical (HPV) Co-Testing cytology, for cervical cancer screening for women ages 30 through 65, once every five years. CPT-4 Code HPV Co-Testing Description 87624 HPV, high-risk types Additional Information Additional ICD-10- CM code Z11.51 is required.

13 Family Planning-Related Services: Management of Sexually Transmitted Infections (STIs) Treatment or diagnostic testing of specified sexually transmitted infections (STIs) may be provided as clinically indicated. For services to manage a complication of family planning-related treatment, refer to Family Planning-Related Services (9) Code Description Procedures Laboratory Supplies Medications (8) Z20.2 Use Z20.2 for diagnosis and treatment of an asymptomatic partner exposed to active case of Chlamydia, Gonorrhea, Syphilis, or Trichomoniasis (M/F) A56.01 A56.09 A56.3 * N34.2 N45.3 N72 N89.8 N94.10 N94.11 N94.12 N94.19 N94.89 R30.0 R30.9 Z20.2 Chlamydia CT cystitis and urethritis (M/F) Other chlamydial infection lower of genitourinary tract (F) CT anus/rectum (M/F) Presumptive Dx Other urethritis (M) Epididymo-orchitis (M) Inflammatory disease of cervix uteri (F) Other specified non-inflammatory disorders of vagina (F) Unspecified dyspareunia (F) Superficial (introital) dyspareunia (F) Deep dyspareunia (F) Other specified dyspareunia (F) Other conditions associated with female genital organs (F) Dysuria (M/F) Painful micturition, unspecified (M/F) STI (CT)-exposed partner (M/F) 87205: Gram stain symptomatic males only 87491: CT, amplified probe technique Azithromycin Doxycycline

14 A54.5 * A54.6 * A54.22 A54.03 Family Planning-Related Services (9) Code Description Procedures Laboratory Supplies Medications (8) Gonorrhea 87205: Gram stain A54.01 GC cystitis and urethritis, unspecified symptomatic (M/F) males only GC pharyngitis (M/F) GC anus/rectum (M/F) GC prostatitis (M) GC cervicitis, unspecified (F) 87591: GC, amplified probe technique Azithromycin Cefixime Ceftriaxone Doxycycline N34.2 N45.3 N72 N89.8 N94.10 N94.11 N94.12 N94.19 N94.89 R30.0 R30.9 Z20.2 Presumptive Dx Other urethritis (M) Epididymo-orchitis (M) Inflammatory disease of cervix uteri (F) Other specified non-inflammatory disorders of vagina (F) Unspecified dyspareunia (F) Superficial (introital) dyspareunia (F) Deep dyspareunia (F) Other specified dyspareunia (F) Other conditions associated with female genital organs (F) Dysuria (M/F) Painful micturition, unspecified (M/F) STI (GC)-exposed partner (M/F)

15 Family Planning-Related Services (9) Code Description Procedures Laboratory Supplies Medications (8) Herpes (genital only) Additional Acyclovir A60.01 A60.04 Herpes penis HSV Vulvovaginitis Restrictions Apply (12) N48.5 N76.6 Presumptive Dx Ulcer of penis Ulceration of vulva 87252: HSV culture 87255: HSV culture N70.03 N70.93 N94.10 N94.11 N94.12 N94.19 N94.89 A51.0 A51.31 A51.39 A51.5 A52.8 A53.0 PID (uncomplicated outpatient only) Acute salpingitis and oophoritis Salpingitis and oophoritis, unspecified Unspecified dyspareunia (F) Superficial (introital) dyspareunia (F) Deep dyspareunia (F) Other specified dyspareunia (F) Other conditions associated with female genital organs (F) Syphilis Primary genital (M/F) Condyloma latum (M/F) Other, secondary (M/F) Early, latent (M/F) Late, latent (M/F) Latent, unspecified (M/F) 99000: Handling and/or conveyance of blood specimen for transfer to lab 99000: Handling and/or conveyance of blood specimen for transfer to lab 87273: HSV DFA Type II 85025: CBC/diff 85651: ESR 85652: ESR 87491: CT, amplified probe technique 87591: GC, amplified probe technique 86593: Syphilis test, nontreponemal antibody; quantitative (15) Azithromycin Ceftriaxone injection Cefoxitin injection Doxycycline Metronidazole Ofloxacin Probenecid Penicillin G benzathine long acting injection Doxycycline N48.5 N76.6 Z20.2 Presumptive Dx Ulcer of penis Ulceration of vulva STI (Syphilis) exposed partner A59.01 A59.03 N34.2 Z20.2 Trichomoniasis Trichomonal vulvo-vaginitis Trich. cystitis and urethritis Presumptive Dx Other urethritis (M) STI (Trichomoniasis) exposed partner (M/F) 83986: ph (females only) 87210: Wet mount Q0111: Wet mount Metronidazole Tinidazole (16)

16 Family Planning-Related Services (9) Code Description Procedures Laboratory Supplies Medications (8) B37.3 N76.0 Vulvovaginitis Candidiasis of vulva and vagina Acute vaginitis 83986: ph (females only) Clotrimazole Fluconazole 87210: Wet mount Miconazole Q0111 Wet mount Terconazole * (27) A63.0 B08.1 B07.9 Warts (genital only) Anogenital (venereal) warts (M/F) Molluscum (M/F) Viral wart, unspecified (M/F) 54050: Destruction of penile lesion; chemical (14) 54056: Destruction of penile lesion; cryo (14) 88305: Surgical path for males (17) 54050UA 54056UA 54100UA 56501UA 57061UA Clindamycin Metronidazole Imiquimod Podofilox 54100: Biopsy of penis (17) 56605UA 56501: Destruction vulvar lesion (14) 57061: Destruction vaginal lesion (14) 88305: Surgical path for females (17) 56605: Biopsy, vulva (17)

17 Family Planning-Related Services: Management of Urinary Tract Infection (UTI) Treatment or diagnostic tests for the management of urinary tract infection (UTI) are covered when provided as part of, or as a follow-up to, a family planning visit where the UTI was identified or diagnosed. An additional code is required as noted below. se benefits are for female clients only. Family Planning-Related Services Code Description Procedures Laboratory Supplies Medications UTI 81000: UA Cephalexin N30.00 N30.01 R31.0 R30.0 R30.9 R35.0 R10.30 Acute cystitis without hematuria Acute cystitis with hematuria Gross hematuria Dysuria Painful micturition, unspecified Frequency of micturition Lower abdominal pain, unspecified dipstick w/microscopy 81001: UA automated w/microscopy Ciprofloxacin Nitrofurantoin TMP/SMX 81002: UA dipstick w/out microscopy 81003: UA automated w/out microscopy 81005: UA (qualitative) 81015: Urine microscopy

18 Family Planning-Related Services: Management of Cervical Abnormalities Treatment and management of specified cervical abnormalities are covered when provided as part of, or as a follow-up to, a family planning visit, where the cervical abnormality was identified or Family Planning-Related Services Code Description Procedures Laboratory Supplies Medications R87.610 R87.619 Abnormal result, cytologic smear of cervix 88141: Pap requiring physician interpretation R87.610 R87.611 R87.612 R87.613 R87.810 N88.0 ASC-US ASC-H LGSIL HGSIL Cervical high risk HPV DNA test positive Presumptive Dx. Leukoplakia, cervix 57452: Colposcopy 57454: Colpo with biopsy & ECC 57455: Colpo with biopsy 57456: Colpo with ECC 87624: HPV, high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) (18) 88305: Surgical pathology 57452UA 57454UA 57455UA 57456UA R87.619 Unspecified abnormal cytological findings in specimen from cervix uteri 57452: Colposcopy 57454: Colpo with biopsy & ECC 57455: Colpo with biopsy 87624: HPV, high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) (18) 88305: Surgical pathology 57452UA 57454UA 57455UA 57456UA 58110UA 57456: Colpo with ECC 58110: Endometrial biopsy w/colpo (19)

19 Family Planning-Related Services Code Description Procedures Laboratory Supplies Medications N87.0 N87.1 D06.9 CIN 1 (biopsy) CIN 2 (biopsy) CIN 3 (biopsy) 57452: Colposcopy 57452UA 57454UA 57454: Colpo with biopsy & ECC 57455: Colpo with biopsy 87624: HPV, high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) (18) 88305: Surgical pathology 57455UA 57456UA 57511UA 57456: Colpo with ECC 57511: Cryocautery of cervix (22) 57460: LEEP (22) R87.618 Other abnormal cytological findings 58100: Endometrial biopsy (20) 88307: Surgical pathology (21) 88305: Surgical pathology 57460UA 58100UA

20 TREATMENT AND DISPENSING GUIDELINES FOR CLINICIANS Family Planning-Related Conditions Drug Regimens CONDITION MEDICATION DOSAGE SIZE REGIMENS * FILL FREQ DAYS NOTES 250mg/500mg 500mg PO BID X 7 days 15 Metronidazole tabs Recommended 0.75% vaginal gel 5g PV QHS X 5 days 30 Bacterial Recommended Vaginosis 2% cream 5g PV X 7 days 30 Clindamycin 150mg capsules 300mg PO BID X 7 days 15 100mg ovules 100mg PV QHS X 3 days 30 Alternative CLINIC CODE Chlamydia Epididymitis External Genital Warts Genital Herpes Azithromycin 500mg tabs/1gm pkt 1gm PO X 1 Doxycycline 100mg tabs 100mg PO BID X 7days Ceftriaxone AND Doxycycline Imiquimod Podofilox Acyclovir 2 per rolling 30 days 250mg injection 250mg IM X 1 100mg tabs 5% cream 0.5% solution/gel 200mg tabs 400mg tabs 400mg tabs 800mg tabs 100mg PO BID X 10 days QHS 3/wks up to 16 weeks BID 3 days/wk followed by 4 days no treatment up to 4 weeks 200mg PO 5/day X 5 or 10 days 400mg PO TID X 5 or 10 days 400 PO TID X 5 days 800mg PO BID X 5 days OR 800mg PO TID x 2 days 2 per rolling 30 days 400mg tabs 400mg PO BID 30 30 30 30 30 30 Recommended Recommended Recommended Primary Recurrent herpes Suppression of recurrent herpes Q0144 J0696

21 Family Planning-Related Conditions Drug Regimens CONDITION MEDICATION DOSAGE SIZE REGIMENS * FILL FREQ DAYS NOTES CLINIC CODE Gonorrhea (see Note 4) Ceftriaxone 250mg injection 250mg IM X 1 15 Recommended 2 per PLUS 1gm 1gm PO X 1 rolling Azithromycin (see Note 1) 30 days Cefixime 400mg tabs 400 mg PO X 1 15 PLUS 1gm 1gm PO X 1 2 per Azithromycin OR rolling Doxycycline 100mg tabs 100mg PO BID X 7 days 30 days Alternative (see Note 1) J0696 Q0144 Q0144 Ceftriaxone OR 250mg injection 250mg IM X 1 J0696 PID Cefoxitin WITH Probenecid PLUS Doxycycline WITH OR WITHOUT Metronidazole Ceftriaxone PLUS Azithromycin WITH OR WITHOUT Metronidazole 1gm injection 2gm IM X 1 500mg tabs 1gm PO X 1 30 100mg tabs 250/500mg tabs 100mg PO BID X 14 days 500mg PO BID X 14 days 250mg injection 250mg IM X 1 1gm 250/500mg tabs 1gm PO once a week for 2 weeks 500mg PO BID X 14 days 2 per rolling 30 days 30 2 per rolling 30 days Recommended (see Note 2) Alternative (see Note 2) J0694 Ofloxacin 200/400mg tabs 400mg PO BID X 14 days 30 (see Note 3) Alternative WITH OR WITHOUT Metronidazole 1gm 250/500mg tabs 500mg PO BID X 14 days 30 (see Note 2)

22 Family Planning-Related Conditions Drug Regimens CONDITION MEDICATION DOSAGE SIZE REGIMENS * FILL FREQ DAYS NOTES CLINIC CODE Recurrent/ Persistent NGU or Cervicitis Moxifloxacin 400mg tabs 400mg PO QD x 7 days (see Note 5) Syphilis Trichomoniasis Urinary Tract Infection Penicillin G benzathine 1.2mil units/2 ml 2.4mil units/4 ml 2.4mil units IM X 1 Doxycycline 100mg tabs 100mg PO BID X 2 weeks 30 Penicillin G benzathine 1.2mil units/2 ml 2.4mil units/4 ml 2.4mil units IM q wk X 3 doses Doxycycline 100mg tabs 100mg PO BID X 4 weeks 30 Metronidazole 500mg tabs 2gm PO X 1 15 500mg PO BID X 7 days 15 Primary, secondary, early latent syphilis Alternative Late latent, unknown duration syphilis Alternative Recommended Alternative Tinidazole 250/500mg tabs 2gm PO X 1 15 (see Note 6) SMX/TMP DS 800/160mg tabs 800/160mg PO BID X 3 days 15 SMX/TMP 400/80mg tabs 400/80mg 2 PO BID X 3 days Ciprofloxacin 250mg tabs 250mg PO BID X 3 days 15 Cephalexin Nitrofurantoin 500mg caps 500mg PO BID X 7-10 days 15 250mg caps 250mg PO QID X 7-10 days 15 50mg/100mg caps/tabs 15 100mg PO BID x 5 days 15 Recommended Alternative Alternative Recommended Alternative Recommended (see Note 7) J0561 J0561

23 Family Planning-Related Conditions Drug Regimens CONDITION MEDICATION DOSAGE SIZE REGIMENS * FILL FREQ DAYS NOTES CLINIC CODE Vaginal Candidiasis Clotrimazole 2% cream QHS for 3 days 30 1% cream QHS for 7 days 30 Fluconazole 150mg tablet Single dose PO 30 Miconazole Terconazole + 4% cream QHS for 3 days 30 2% cream QHS for 7 days 30 200mg vaginal suppository QHS for 3 days 30 100mg vaginal suppository QHS for 7 days 30 80mg suppository QHS for 3 days 30 Reserve for use in complicated cases of 0.8% cream QHS for 3 days 30 Vaginal Candidiasis. Restricted to Pharmacy 0.4%cream QHS for 7 days 30 dispensing only; for use after treatment failure with other anti-fungals, TAR required. NA

24 CONTRACEPTIVE SUPPLIES Condoms, male Condoms, female Spermicidal Gel/Jelly/Foam/Cream Spermicidal Suppository Spermicidal Vaginal Film Spermicidal Contraceptive Sponge Lubricant Family PACT Contraceptive Supplies BILLING UNIT each each per gram each each each per gram MAXIMUM QUANTITY ONSITE (see Note 8) EARLIEST REFILL: ONSITE 15 days REFILL FREQUENCY LIMIT PHARMACY Male Condoms up to 36 units per 27 days Female Condoms up to 6 units per 27 days All other contraceptive supplies are limited to 3 refills in any 75- day period CLINIC CODE A4267 A4268 A4269U1 A4269U2 A4269U3 A4269U4 S5199 Basal Body Thermometer each N/A N/A 1 per year NA Contraceptive Diaphragm each N/A N/A Limited to 1 diaphragm per year NA Contraceptive Cervical Cap (Fem Cap) each N/A N/A Limited to 2 cervical caps per year NA CONTRACEPTIVES DOSAGE SIZE Family PACT Contraceptives MAXIMUM QUANTITY: ONSITE EARLIEST REFILL: ONSITE MAXIMUM QUANTITY: PHARMACY EARLIEST REFILL: PHARMACY Oral Contraceptives 1 cycle 13 cycles (see Note 9) 13 cycles (see Note 9) S4993 Contraceptive Patch 1 patch 36 patches (see Note 9) 36 patches (see Note 9) J7304 Contraceptive Vaginal Ring 1 ring 12 rings (see Note 9) 12 rings (see Note 9) J7303 CLINIC CODE Medroxyprogesterone Acetate 1 injection 1 injection 80 days N/A N/A J3490U8 Intrauterine copper contraceptive 1 IUC 1 IUC 1 year N/A N/A J7300 Etonogestrel Contraceptive Implant 1 implant 1 implant 34 months N/A N/A J7307 Levonorgestrel IU 52 mg 3 yr 1 IUC 1 IUC N/A N/A J7297 Levonorgestrel IU 52 mg 5 yr 1 IUC 1 IUC N/A N/A J7298 Levonorgestrel IU 13.5 mg 1 IUC 1 IUC N/A N/A J7301 Emergency contraception: Levonorgestrel 0.75 mg Levonorgestrel 1.5 mg Ulipristal Acetate 30 mg 1 pack (2 tablets) 1 pack (1 tablet) 1 pack (1 tablet) 1 packet/ event combined maximum of 6 packs/year As medically indicated up to limit 1 pack/ event combined maximum of 6 packs/year As medically indicated up to limit J3490U6 J3490U6 J3490U5